| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 231.6K | $10.42M | - | |
| CFO | 158.7K | $7.14M | - | |
| VP | 111.5K | $5.02M | - | |
| COO | 27.9K | $1.26M | - | |
| Dir | 25.7K | $1.16M | -2,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2017 | Mitchell Paul J | Director | Sale+OE | 1,500 | $58.31 | $87,465.00 | -15.8% | |
| Mar 29, 2017 | Cooke Shane62 | President, Alkermes Plc | Sale+OE | 2,070 | $60.00 | $124,200.00 | -2.8% | |
| Mar 23, 2017 | Cooke Shane62 | President, Alkermes Plc | Sale+OE | 6,030 | $60.01 | $361,856.08 | -7.7% | |
| Mar 21, 2017 | Cooke Shane62 | President, Alkermes Plc | Sale+OE | 1,900 | $60.09 | $114,162.40 | -1.3% | |
| Mar 15, 2017 | Ehrich Elliot | EVP, R&D &CMO, Alkermes, Inc. | Sale+OE | 11,000 | $56.74 | $624,107.24 | -8.6% | |
| Mar 7, 2017 | Frates James M83 | SVP, Alks Inc; CFO Alks | Sale+OE | 25,000 | $59.08 | $1,477,068.08 | -9.5% | |
| Mar 2, 2017 | Breyer Robert A | Director | Sell | 4,000 | $60.00 | $240,000.00 | -35.9% | |
| Mar 2, 2017 | Cooke Shane62 | President, Alkermes Plc | Sale+OE | 20,000 | $60.00 | $1,200,000.00 | -22.4% | |
| Mar 1, 2017 | Mitchell Paul J | Director | Sale+OE | 1,500 | $57.06 | $85,590.00 | -15.8% | |
| Feb 16, 2017 | Ehrich Elliot | EVP, R&D &CMO, Alkermes, Inc. | Sale+OE | 11,000 | $56.68 | $623,441.49 | -6.6% |